Revised version (INFD-D-20-00242): impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective study.
Axel UrsenbachFrédéric SchrammFrançois SéveracYves HansmannNicolas LefebvreYvon RuchXavier ArgemiPublished in: BMC infectious diseases (2021)
In all, 16S PCR analysis has a significant clinical impact on patient management, particularly for suspected CSF infections, for patients with culture-negative samples and for those with previous antibiotic treatments.